Analysis of the mechanism of ultraviolet irradiation-mediated induction skin malignant melanoma
紫外线照射介导诱发皮肤恶性黑色素瘤的机制分析
基本信息
- 批准号:12670816
- 负责人:
- 金额:$ 2.5万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We previously established three lines of RET oncogene-transgenic mice. In all of these three lines of transgenic mice skin melanosis developed soon after birth. Melanocytic tumors developed in lines 304 and 192 but not in line 242 during ageing. Malignant skin melanoma also developed in line 304 which had been crossed repeatedly with C57BL (line 304/B6), but not in line 192. Using these transgenic mouse lines, we analyzed the mechanism of ultraviolet irradiation-mediated induction of skin malignant melanoma. When line 192 of transgenic mice were irradiated repeatedly with ultraviolet light for 7 months skin, malignant melanoma developed. Ultraviolet irradiation of line 242 of transgenic mice, however, did not induce the development of melanocytic tumors. These results suggested that ultraviolet irradiation affects the step of tumor promotion from benign to malignant but not the step of the initial development of tumor. We then showed that ultraviolet irradiation of either RET-transgenic mice or NIH3T3 cells that carried RET oncogene induced activation of RET kinase. The mechanism of activation of RET kinase by ultraviolet irradiation was then examined. Mutant RETs in which each of the conserved cysteine residues in the kinase domain was replaced with alanine were prepared, and the levels of catalytic activity and reactivity to ultraviolet irradiation required for augmention of the activity of these mutant RETs were measured. We found in this study that structural modification through oxidation of a conserved cysteine residue (Cys-987 of c-RET) causes dimerization or polymerization of RET antigens, which accompanies an increase in catalytic activity of RET. It was speculated from these results that ultraviolet irradiation, which is long known to injure DNA and membrane lipid, also affects proteins for modification of structure and function and this mechanism plays a role in the promotion of benign melanocytictumors to malignant melanoma.
我们以前建立了三条RET癌基因 - 转基因小鼠。在这三种三线的转基因小鼠中,皮肤黑色素病在出生后不久就出现了。黑素细胞肿瘤在第304和192行开发,但在衰老期间不在242行中。恶性皮肤黑色素瘤也在第304号线中发育而成,该第304号线与C57BL反复交叉(第304/B6行),但在第192行中不反复交叉。使用这些转基因小鼠系,我们分析了紫外线辐照介导的诱导皮肤恶性肿瘤的机制。当第192行的转基因小鼠用紫外线反复辐照7个月的皮肤时,恶性黑色素瘤就会发展出来。但是,转基因小鼠第242行的紫外线辐射并未诱导黑素细胞肿瘤的发展。这些结果表明,紫外线辐射会影响肿瘤从良性到恶性的促进的步骤,但不影响肿瘤初始发展的步骤。然后,我们证明了携带RET癌基因诱导的RET激酶激活的RET-转基因小鼠或NIH3T3细胞的紫外线照射。然后检查了通过紫外线辐射激活RET激酶的机制。突变体RET在激酶结构域中的每个保守的半胱氨酸残基被制备代替丙氨酸,并测量了增强这些突变体RET活性所需的催化活性和对紫外线辐照的反应水平。我们在这项研究中发现,通过氧化保守的半胱氨酸残基(C-987)的结构修饰会导致RET抗原的二聚化或聚合,从而伴随RET的催化活性增加。从这些结果中可以推测,紫外线辐射(长期以来已知会损害DNA和膜脂质)也会影响蛋白质的结构和功能修饰,并且这种机制在促进良性黑素细胞肿瘤对恶性黑色素瘤的促进中起作用。
项目成果
期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takeda, K.: "Osmotic stress-mediated activation of RET kinases involves intracellular disulfide-bonded dimer formation"Antioxidants & Redox Signaling. (in press). 473-482 (2002)
Takeda, K.:“渗透压介导的 RET 激酶激活涉及细胞内二硫键二聚体的形成”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kato, M.: "Molecular mechanism of activation and superactivation of Ret tyrosine kinases by ultraviolet light irradiation"Antioxidants & Redox Signaling. 2. 841-849 (2000)
Kato, M.:“紫外线照射下 Ret 酪氨酸激酶激活和超激活的分子机制”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kato, M.: "Ultraviolet inudces redox reaction-mediated dimerization and superactivation of oncogenic Ret tyrosine kinases"Mol. Biol. Cell. 11. 93-101 (2000)
Kato, M.:“紫外线诱导氧化还原反应介导的致癌 Ret 酪氨酸激酶的二聚化和超活化”Mol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kato, M, Takeda, K., Kawamoto, Y., Iwashita, T., Akhand. A.A., Senga, T., Yamamoto, M., Sobue, G., Hamaguchi, M., Takahashi, M., Nakashima, J.: "Repair by Src Kinase of Function-Impaired RET-MEN2A with Mutations at Tyrosines in the Carboxyterminal Kinase
加藤,M,武田,K.,川本,Y.,岩下,T.,阿坎德。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
中島泉: "Chemical reaction-mediated alternative signalling pathway in cells of the immune system."Current Trends in Immunology. 3. 45-58 (2000)
Izumi Nakajima:“免疫系统细胞中化学反应介导的替代信号传导途径。”《免疫学当前趋势》3. 45-58 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKASHIMA Izumi其他文献
NAKASHIMA Izumi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKASHIMA Izumi', 18)}}的其他基金
Study on redox-linked regulatory mechanism of intracellular signal transduction for differentiation and death of T lymphocytes
T淋巴细胞分化和死亡的细胞内信号转导氧化还原调控机制研究
- 批准号:
14390026 - 财政年份:2002
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Blocking tumor progression in therapy-responsive RET aberration-associated cancer
阻断治疗反应性 RET 畸变相关癌症的肿瘤进展
- 批准号:
10064377 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
Blocking tumor progression in therapy-responsive RET aberration-associated cancer
阻断治疗反应性 RET 畸变相关癌症的肿瘤进展
- 批准号:
10413049 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
Blocking tumor progression in therapy-responsive RET aberration-associated cancer
阻断治疗反应性 RET 畸变相关癌症的肿瘤进展
- 批准号:
10615797 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
Blocking tumor progression in therapy-responsive RET aberration-associated cancer
阻断治疗反应性 RET 畸变相关癌症的肿瘤进展
- 批准号:
10229620 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
CDK9 and cyclin regulators in Medullary Thyroid Cancer
甲状腺髓样癌中的 CDK9 和细胞周期蛋白调节因子
- 批准号:
9753185 - 财政年份:2016
- 资助金额:
$ 2.5万 - 项目类别: